cp-751,871
Showing 1 - 13 of 13
Head Neck Cancer Trial in Yvoir, Bruxelles (CP-751,871)
Terminated
- Head and Neck Cancer
- CP-751,871
-
Yvoir, Namur, Belgium
- +1 more
Apr 19, 2016
Ewing's Sarcoma Family of Tumors Trial in Worldwide (CP-751,871)
Completed
- Ewing's Sarcoma Family of Tumors
- CP-751,871
-
Tampa, Florida
- +36 more
Oct 6, 2015
Breast Tumors Trial in Worldwide (CP-751,871, exemestane, Fulvestrant)
Terminated
- Breast Neoplasms
- CP-751,871
- +2 more
-
La Jolla, California
- +62 more
Oct 6, 2015
NSCLC Trial (CP-751,871, Cisplatin, Gemcitabine)
Withdrawn
- Carcinoma, Non-Small-Cell Lung
- CP-751,871
- +2 more
- (no location specified)
Jun 16, 2014
Advanced Cancer, Advanced Solid Tumors Trial in United States (CP-751,871, Sunitinib)
Terminated
- Advanced Cancer
- Advanced Solid Tumors
- CP-751,871
- Sunitinib
-
Los Angeles, California
- +3 more
May 21, 2014
Sarcoma, Solid Tumor Trial in Boston (RAD001, CP-751,871)
Completed
- Sarcoma
- Solid Tumor
- RAD001
- CP-751,871
-
Boston, MassachusettsDana-Farber Cancer Institute
Nov 12, 2013
Advanced Non-Hematologic Malignancies Trial in Sutton (CP-751,871, Docetaxel)
Completed
- Advanced Non-Hematologic Malignancies
- CP-751,871
- Docetaxel
-
Sutton, Surrey, United KingdomPfizer Investigational Site
Oct 4, 2013
NSCLC Trial in Worldwide (CP-751,871, paclitaxel, carboplatin)
Completed
- Carcinoma, Non-Small-Cell Lung
- CP-751,871
- +3 more
-
Tucson, Arizona
- +30 more
Oct 1, 2013
NSCLC Trial in Belgium, Ireland, Spain (CP-751,871, Cisplatin, Gemcitabine)
Completed
- Carcinoma, Non-Small-Cell Lung
- CP-751,871
- +3 more
-
Charleroi, Belgium
- +3 more
Mar 15, 2013
Prostatic Tumors Trial in Worldwide (CP-751,871, docetaxel, prednisone)
Completed
- Prostatic Neoplasms
- CP-751,871
- +2 more
-
Los Angeles, California
- +17 more
Mar 5, 2013